Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIBIK Drug Use Surveillance
jRCT1080223795Completed
- Sponsor
- Research Foundation for Microbial Diseases of Osaka University
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride in diphtheria, pertussis and Tetanus, sponsored by Research Foundation for Microbial Diseases of Osaka University. Started Feb 2018; status: completed.
02
Drugs
bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride
03
Conditions
diphtheriapertussisTetanus
Beyond the preview
Go deeper on jRCT1080223795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223795.